Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3637815
Max Phase: Preclinical
Molecular Formula: C12H10N4O2S2
Molecular Weight: 306.37
Molecule Type: Small molecule
Associated Items:
ID: ALA3637815
Max Phase: Preclinical
Molecular Formula: C12H10N4O2S2
Molecular Weight: 306.37
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: Cc1ccc2oc(SCC(=O)Nc3nccs3)nc2n1
Standard InChI: InChI=1S/C12H10N4O2S2/c1-7-2-3-8-10(14-7)16-12(18-8)20-6-9(17)15-11-13-4-5-19-11/h2-5H,6H2,1H3,(H,13,15,17)
Standard InChI Key: WZDNTLZQCPQIGQ-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 306.37 | Molecular Weight (Monoisotopic): 306.0245 | AlogP: 2.72 | #Rotatable Bonds: 4 |
Polar Surface Area: 80.91 | Molecular Species: NEUTRAL | HBA: 7 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 6 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 7.86 | CX Basic pKa: 0.94 | CX LogP: 1.82 | CX LogD: 1.69 |
Aromatic Rings: 3 | Heavy Atoms: 20 | QED Weighted: 0.75 | Np Likeness Score: -2.74 |
1. Rebollo-Lopez, M. J.; Lelièvre, J.; Alvarez-Gomez, D.; Castro-Pichel, J.; Martínez-Jiménez, F.; Papadatos, G.; Kumar, V.; Colmenarejo, G.; Mugumbate, G.; Hurle, M.; Barroso, V.; Young, R. J.; Martinez-Hoyos, M.; González del Río, R.; Bates, R. H.; Lopez-Roman, E. M.; Mendoza-Losana, A.; Brown, J. R.; Alvarez-Ruiz, E.; Marti-Renom, M. A.; Overington, J. P.; Cammack, N.; Ballell, L.; Barros-Aguire, D., . GSK Tres Cantos Follow-up TB Screening Data., [10.6019/CHEMBL3637782] |
Source(1):